Skip Navigation

Erratum for Pelé et al., Hum. Mol. Genet. 14 (11) 1417-1427.
Human Molecular Genetics 2005 14(13):1905-1906; doi:10.1093/hmg/ddi201
This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Pelé, M.
Right arrow Articles by Panthier, J.-J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Pelé, M.
Right arrow Articles by Panthier, J.-J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org

SINE exonic insertion in the PTPLA gene leads to multiple splicing defects and segregates with the autosomal recessive centronuclear myopathy in dog

Manuel Pelé, Laurent Tiret, Jean-Louis Kessler, Stéphane Blot and Jean-Jacques Panthier

Human Molecular Genetics 14, 1417–1427 (2005)

The publishers would like to apologise for the following errors that appeared in this paper. On page 1423, the first paragraph, 16th line, the text should read ‘(HCX2GX2R)’ not ‘(HCX26X2R)’. The complete and correct sentence is given as follows:

Ptpla was first annotated in mouse and then in human on the basis of a putative protein tyrosine phosphatase-like catalytic site, with a proline replacing arginine in the consensus (HCX2GX2R) sequence (32,33).

An error has also occurred in the references section of this paper. Reference five should have been deleted, and subsequent references renumbered. The correct set of references are printed subsequently.

REFERENCES

  1. Karpati, G., Carpenter, S. and Nelson, R.F. (1970) Type I muscle fibre atrophy and central nuclei. A rare familial neuromuscular disease. J. Neurol. Sci., 10, 489–500.[CrossRef][Web of Science][Medline]

  2. Wallgren-Pettersson, C., Clarke, A., Samson, F., Fardeau, M., Dubowitz, V., Moser, H., Grimm, T., Barohn, R.J. and Barth, P.G. (1995) The myotubular myopathies: differential diagnosis of the X linked recessive, autosomal dominant, and autosomal recessive forms and present state of DNA studies. J. Med. Genet., 32, 673–679.[Abstract/Free Full Text]

  3. Jeannet, P.Y., Bassez, G., Eymard, B., Laforet, P., Urtizberea, J.A. Rouche, A., Guicheney, P., Fardeau, M. and Romero, N.B. (2004) Clinical and histologic findings in autosomal centronuclear myopathy. Neurology, 62, 1484–1490.[Abstract/Free Full Text]

  4. Meyers, K.R., Golomb, H.M., Hansen, J.L. and McKusick, V.A. (1974) Familial neuromuscular disease with ‘myotubes’. Clin. Genet., 5, 327–337.[Web of Science][Medline]

  5. Herman, G.E., Finegold, M., Zhao, W., de Gouyon, B. and Metzenberg, A. (1999) Medical complications in long-term survivors with X-linked myotubular myopathy. J. Pediatr., 134, 206–214.[CrossRef][Web of Science][Medline]

  6. Helliwell, T.R., Ellis, I.H. and Appleton, R.E. (1998) Myotubular myopathy: morphological, immunohistochemical and clinical variation. Neuromuscul. Disord., 8, 152–161.[CrossRef][Web of Science][Medline]

  7. Hu, L.J., Laporte, J., Kioschis, P., Heyberger, S., Kretz, C., Poustka, A., Mandel, J.L. and Dahi, N. (1996) X-linked myotubular myopathy: refinement of the gene to a 280-kb region with new and highly informative microsatellite markers. Hum. Genet., 98, 178–181.[CrossRef][Web of Science][Medline]

  8. Laporte, J., Hu, L.J., Kretz, C., Mandel, J.L., Kioschis, P., Coy, J.F., Klauck, S.M., Poustka, A. and Dahl, N. (1996) A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast. Nat. Genet., 13, 175–182.[CrossRef][Web of Science][Medline]

  9. Biancalana, V., Caron, O., Gallati, S., Baas, F., Kress, W., Novelli, G., D'Apice, M.R., Lagier-Tourenne, C., Buj-Bello, A., Romero, N.B. et al. (2003) Characterisation of mutations in 77 patients with X-linked myotubular myopathy, including a family with a very mild phenotype. Hum. Genet., 112, 135–142.[Web of Science][Medline]

  10. Blondeau, F., Laporte, J., Bodin, S., Superti-Furga, G., Payrastre, B. and Mandel, J.L. (2000) Myotubularin, a phosphatase deficient in myotubular myopathy, acts on phosphatidylinositol 3-kinase and phosphatidylinositol 3-phosphate pathway. Hum. Mol. Genet., 9, 2223–2229.[Abstract/Free Full Text]

  11. Taylor, G.S., Maehama, T. and Dixon, J.E. (2000) Inaugural article: myotubularin, a protein tyrosine phosphatase mutated in myotubular myopathy, dephosphorylates the lipid second messenger, phosphatidylinositol 3-phosphate. Proc. Natl Acad. Sci. USA, 97, 8910–8915.[Abstract/Free Full Text]

  12. Laporte, J., Blondeau, F., Buj-Bello, A. and Mandel, J.L. (2001) The myotubularin family: from genetic disease to phosphoinositide metabolism. Trends Genet., 17, 221–228.[CrossRef][Web of Science][Medline]

  13. Schaletzky, J., Dove, S.K., Short, B., Lorenzo, O., Clague, M.J. and Barr, F.A. (2003) Phosphatidylinositol-5-phosphate activation and conserved substrate specificity of the myotubularin phosphatidylinositol 3-phosphatases. Curr. Biol., 13, 504–509.[CrossRef][Web of Science][Medline]

  14. Tronchere, H., Laporte, J., Pendaries, C., Chaussade, C., Liaubet, L., Pirola, L., Mandel, J.L. and Payrastre, B. (2004) Production of phosphatidylinositol 5-phosphate by the phosphoinositide 3-phosphatase myotubularin in mammalian cells. J. Biol. Chem., 279, 7304–7312.[Abstract/Free Full Text]

  15. Bolino, A., Muglia, M., Conforti, F.L., LeGuern, E., Salih, M.A., Georgiou, D.M., Christodoulou, K., Hausmanowa-Petrusewicz, I., Mandich, P., Schenone, A. et al. (2000) Charcot–Marie–Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2. Nat. Genet., 25, 17–19.[CrossRef][Web of Science][Medline]

  16. Azzedine, H., Bolino, A., Taieb, T., Birouk, N., Di Duca, M., Bouhouche, A., Benamou, S., Mrabet, A., Hammadouche, T., Chkili, T. et al. (2003) Mutations in MTMR13, a new pseudophosphatase homologue of MTMR2 and Sbf1, in two families with an autosomal recessive demyelinating form of Charcot–Marie–Tooth disease associated with early-onset glaucoma. Am. J. Hum. Genet., 72, 1141–1153.[CrossRef][Web of Science][Medline]

  17. Senderek, J., Bergmann, C., Weber, S., Ketelsen, U.P., Schorle, H., Rudnik-Schoneborn, S., Buttner, R., Buchheim, E. and Zerres, K. (2003) Mutation of the SBF2 gene, encoding a novel member of the myotubularin family, in Charcot–Marie–Tooth neuropathy type 4B2/11p15. Hum. Mol. Genet., 12, 349–356.[Abstract/Free Full Text]

  18. Laporte, J., Bedez, F., Bolino, A. and Mandel, J.L. (2003) Myotubularins, a large disease-associated family of cooperating catalytically active and inactive phosphoinositides phosphatases. Hum. Mol. Genet., 12, R285–292.[Abstract/Free Full Text]

  19. Nandurkar, H.H., Caldwell, K.K., Whisstock, J.C., Layton, M.J., Gaudet, E.A., Norris, F.A., Majerus, P.W. and Mitchell, C.A. (2001) Characterization of an adapter subunit to a phosphatidylinositol (3)P 3-phosphatase: identification of a myotubularin-related protein lacking catalytic activity. Proc. Natl Acad. Sci. USA, 98, 9499–9504.[Abstract/Free Full Text]

  20. Nandurkar, H.H. and Huysmans, R. (2002) The myotubularin family: novel phosphoinositide regulators. IUBMB Life, 53, 37–43.[Web of Science][Medline]

  21. Kim, S.A., Vacratsis, P.O., Firestein, R., Cleary, M.L. and Dixon, J.E. (2003) Regulation of myotubularin-related (MTMR)2 phosphatidylinositol phosphatase by MTMR5, a catalytically inactive phosphatase. Proc. Natl Acad. Sci. USA, 100, 4492–4497.[Abstract/Free Full Text]

  22. Mochizuki, Y. and Majerus, P.W. (2003) Characterization of myotubularin-related protein 7 and its binding partner, myotubularin-related protein 9. Proc. Natl Acad. Sci. USA, 100, 9768–9773.[Abstract/Free Full Text]

  23. Nandurkar, H.H., Layton, M., Laporte, J., Selan, C., Corcoran, L., Caldwell, K.K., Mochizuki, Y., Majerus, P.W. and Mitchell, C.A. (2003) Identification of myotubularin as the lipid phosphatase catalytic subunit associated with the 3-phosphatase adapter protein, 3-PAP. Proc. Natl Acad. Sci. USA, 100, 8660–8665.[Abstract/Free Full Text]

  24. Kramer, J.W., Hegreberg, G.A., Bryan, G.M., Meyers, K. and Ott, R.L. (1976) A muscle disorder of Labrador retrievers characterized by deficiency of type II muscle fibers. J. Am. Vet. Med. Assoc., 169, 817–820.[Web of Science][Medline]

  25. McKerrell, R.E. and Braund, K.G. (1986) Hereditary myopathy in Labrador retrievers: a morphologic study. Vet. Pathol., 23, 411–417.[Abstract]

  26. Watson, A.D., Farrow, B.R., Middleton, D.J. and Smyth, J.B. (1988) Myopathy in a Labrador retriever. Aust. Vet. J., 65, 226–227.[Web of Science][Medline]

  27. Gortel, K., Houston, D.M., Kuiken, T., Fries, C.L. and Boisvert, B. (1996) Inherited myopathy in a litter of Labrador retrievers. Can. Vet. J., 37, 108–110.[Web of Science][Medline]

  28. Bley, T., Gaillard, C., Bilzer, T., Braund, K.G., Faissler, D., Steffen, F., Cizinauskas, S., Neumann, J., Vogtli, T., Equey, R. et al. (2002) Genetic aspects of Labrador Retriever myopathy. Res. Vet. Sci., 73, 231–236.[CrossRef][Web of Science][Medline]

  29. Tiret, L., Blot, S., Kessler, J.L., Gaillot, H., Breen, M. and Panthier, J.J. (2003) The cnm locus, a canine homologue of human autosomal forms of centronuclear myopathy, maps to chromosome 2. Hum. Genet., 113, 297–306.[CrossRef][Web of Science][Medline]

  30. Kramer, J.W., Hegreberg, G.A. and Hamilton, M.J. (1981) Inheritance of a neuromuscular disorder of Labrador retriever dogs. J. Am. Vet. Med. Assoc., 179, 380–381.[Web of Science][Medline]

  31. Breen, M., Hitte, C., Lorentzen, T.D., Thomas, R., Cadieu, E., Sabacan, L., Scott, A., Evanno, G., Parker, H.G., Kirkness, E.F. et al. (2004) An integrated 4249 marker FISH/RH map of the canine genome. BMC Genomics, 5, 65.[CrossRef][Medline]

  32. Uwanogho, D.A., Hardcastle, Z., Balogh, P., Mirza, G., Thornburg, K.L., Ragoussis, J. and Sharpe, P.T. (1999) Molecular cloning, chromosomal mapping, and developmental expression of a novel protein tyrosine phosphatase-like gene. Genomics, 62, 406–416.[CrossRef][Web of Science][Medline]

  33. Li, D., Gonzalez, O., Bachinski, L.L. and Roberts, R. (2000) Human protein tyrosine phosphatase-like gene: expression profile, genomic structure, and mutation analysis in families with ARVD. Gene, 256, 237–243.[CrossRef][Web of Science][Medline]

  34. Minnick, M.F., Stillwell, L.C., Heineman, J.M. and Stiegler, G.L. (1992) A highly repetitive DNA sequence possibly unique to canids. Gene, 110, 235–238.[CrossRef][Web of Science][Medline]

  35. Antonarakis, S.E. (1998) Recommendations for a nomenclature system for human gene mutations. Nomenclature Working Group. Hum. Mutat., 11, 1–3.[CrossRef][Web of Science][Medline]

  36. Deininger, P.L. and Batzer, M.A. (1999) Alu repeats and human disease. Mol. Genet. Metab., 67, 183–193.[CrossRef][Web of Science][Medline]

  37. Tighe, P.J., Stevens, S.E., Dempsey, S., Le Deist, F., Rieux-Laucat, F. and Edgar, J.D. (2002) Inactivation of the Fas gene by Alu insertion: retrotransposition in an intron causing splicing variation and autoimmune lymphoproliferative syndrome. Genes Immun., 3, S66–S70.

  38. Ganguly, A., Dunbar, T., Chen, P., Godmilow, L. and Ganguly, T. (2003) Exon skipping caused by an intronic insertion of a young Alu Yb9 element leads to severe hemophilia A. Hum. Genet., 113, 348–352.[CrossRef][Web of Science][Medline]

  39. Ricci, V., Regis, S., Di Duca, M. and Filocamo, M. (2003) An Alu-mediated rearrangement as cause of exon skipping in Hunter disease. Hum. Genet., 112, 419–425.[Web of Science][Medline]

  40. Sorek, R., Ast, G. and Graur, D. (2002) Alu-containing exons are alternatively spliced. Genome Res., 12, 1060–1067.[Abstract/Free Full Text]

  41. Mustajoki, S., Ahola, H., Mustajoki, P. and Kauppinen, R. (1999) Insertion of Alu element responsible for acute intermittent porphyria. Hum. Mutat., 13, 431–438.[CrossRef][Web of Science][Medline]

  42. Claverie-Martin, F., Gonzalez-Acosta, H., Flores, C., Anton-Gamero, M. and Garcia-Nieto, V. (2003) De novo insertion of an Alu sequence in the coding region of the CLCN5 gene results in Dent's disease. Hum. Genet., 113, 480–485.[CrossRef][Web of Science][Medline]

  43. Pfaffl, M.W., Horgan, G.W. and Dempfle, L. (2002) Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res., 30, e36.[Abstract/Free Full Text]

  44. Laporte, J., Biancalana, V., Tanner, S.M., Kress, W., Schneider, V., Wallgren-Pettersson, C., Herger, F., Buj-Bello, A., Blondeau, F., Liechti-Gallati, S. et al. (2000) MTM1 mutations in X-linked myotubular myopathy. Hum. Mutat., 15, 393–409.[CrossRef][Web of Science][Medline]

  45. Buj-Bello, A., Laugel, V., Messaddeq, N., Zahreddine, H., Laporte, J., Pellissier, J.F. and Mandel, J.L. (2002) The lipid phosphatase myotubularin is essential for skeletal muscle maintenance but not for myogenesis in mice. Proc. Natl Acad. Sci. USA, 99, 15060–15065.[Abstract/Free Full Text]

  46. Toker, A. (2002) Phosphoinositides and signal transduction. Cell. Mol. Life Sci., 59, 761–779.[CrossRef][Web of Science][Medline]

  47. Oldridge, M., Zackai, E.H., McDonald-McGinn, D.M., Iseki, S., Morriss-Kay, G.M., Twigg, S.R., Johnson, D., Wall, S.A., Jiang, W., Theda, C. et al. (1999) De novo alu-element insertions in FGFR2 identify a distinct pathological basis for Apert syndrome. Am. J. Hum. Genet., 64, 446–461.[CrossRef][Web of Science][Medline]

  48. Miki, Y., Katagiri, T., Kasumi, F., Yoshimoto, T. and Nakamura, Y. (1996) Mutation analysis in the BRCA2 gene in primary breast cancers. Nat. Genet., 13, 245–247.[CrossRef][Web of Science][Medline]

  49. Hentze, M.W. and Kulozik, A.E. (1999) A perfect message: RNA surveillance and nonsense-mediated decay. Cell, 96, 307–310.[CrossRef][Web of Science][Medline]

  50. Cartegni, L., Chew, S.L. and Krainer, A.R. (2002) Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat. Rev. Genet., 3, 285–298.[CrossRef][Web of Science][Medline]

  51. Lin, L., Faraco, J., Li, R., Kadotani, H., Rogers, W., Lin, X., Qiu, X., de Jong, P.J., Nishino, S. and Mignot, E. (1999) The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell, 98, 365–376.[CrossRef][Web of Science][Medline]

  52. Kirkness, E.F., Bafna, V., Halpern, A.L., Levy, S., Remington, K., Rusch, D.B., Delcher, A.L., Pop, M., Wang, W., Fraser, C.M. et al. (2003) The dog genome: survey sequencing and comparative analysis. Science, 301, 1898–1903.[Abstract/Free Full Text]

  53. Britten, R.J. (1996) DNA sequence insertion and evolutionary variation in gene regulation. Proc. Natl Acad. Sci. USA, 93, 9374–9377.[Abstract/Free Full Text]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Pelé, M.
Right arrow Articles by Panthier, J.-J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Pelé, M.
Right arrow Articles by Panthier, J.-J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?